Why is GlaxoSmithKline’s share price falling?
Mar 18, 2022 · GlaxoSmithKline plc (GSK) : Free Stock Analysis Report ... The stock is down more than 25%, and the streaming giant confirmed this is not a blip, it’s an existential crisis. 1d ago.
How did GlaxoSmithKline (GSK) perform in the latest trading session?
Apr 02, 2022 · GlaxoSmithKline's stock was trading at $39.87 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, GSK stock has increased by 16.2% and is now trading at $46.32. View which stocks have been most impacted by COVID-19.
Why is the GSK share price down 6%?
1 hour ago · The GlaxoSmithKline (LSE: GSK) share price has been climbing since early 2021, and it’s up 30% over the past 12 months. But the share’s barely moved when the market opened Wednesday, after ...
What does a hold rating on GlaxoSmithKline stock mean?
Jan 28, 2022 · In the latest trading session, GlaxoSmithKline (GSK) closed at $45.25, marking a -1.07% move from the previous day. This change lagged the S&P 500's daily gain of 2.44%. At the same time, the Dow ...
Is GSK stock a good buy now?
Right now, GlaxoSmithKline is sporting a Zacks Rank of #2 (Buy), while Eli Lilly has a Zacks Rank of #3 (Hold). The Zacks Rank favors stocks that have recently seen positive revisions to their earnings estimates, so investors should rest assured that GSK has an improving earnings outlook.Feb 16, 2022
Is GlaxoSmithKline undervalued?
For PFE, this valuation metric has been as high as 4.52, as low as 2.91, with a median of 3.24 over the past year. These figures are just a handful of the metrics value investors tend to look at, but they help show that GlaxoSmithKline and Pfizer are likely being undervalued right now.Feb 14, 2022
What are prospects for GSK shares worth?
Stock Price Forecast The 18 analysts offering 12-month price forecasts for GlaxoSmithKline PLC have a median target of 45.83, with a high estimate of 55.35 and a low estimate of 36.51. The median estimate represents a +2.05% increase from the last price of 44.91.
Does GSK pay a dividend?
GSK pays a dividend of $2.20 per share. GSK's annual dividend yield is 4.91%. GLAXOSMITHKLINE's dividend is higher than the US industry average of 3.2%, and it is higher than the US market average of 3.41%.
What is the intrinsic value of GSK?
As of today (2022-04-09), GlaxoSmithKline's Intrinsic Value: Projected FCF is $47.25. The stock price of GlaxoSmithKline is $46.64.
Is GSK publicly traded?
The culmination of the Consumer Healthcare string of deals will result in GSK splitting into two separate companies, via a demerger and subsequent listing of the joint venture. This will create two publicly traded companies, one focusing on pharmaceuticals and research & development, the other on consumer healthcare.
Should I buy GSK shares 2021?
There are several reasons to own the stock. Favorable Rank and Rising Estimates and Share Price: Glaxo has a Zacks Rank #1 (Strong Buy). You can see the complete list of today's Zacks #1 Rank stocks here. Earnings estimates for Glaxo's earnings have risen 9.7% for 2021 and 6.2% for 2022 over the past 60 days.Nov 16, 2021
Is GSK a hold?
GlaxoSmithKline PLC holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
Will GSK rise?
Glaxo (ticker: GSK) said sales in 2022 after the spinoff of the consumer arm were expected to rise between 5% to 7%, and adjusted operating profits will grow between 12% to 14%, including the anticipated benefit in royalty income from a settlement with Gilead Sciences (GILD), the company said in a statement on ...Feb 9, 2022
When did Glaxo go ex-dividend?
The next Glaxosmithkline plc dividend will go ex in 28 days for 13.5p and will be paid in 3 months....Dividend Summary.SummaryPrevious dividendNext dividendEx-div date24 Feb 2022 (Thu)19 May 2022 (Thu)Pay date07 Apr 2022 (Thu)07 Jul 2022 (Thu)4 more rows
What is the ex-dividend date for GlaxoSmithKline?
We are a science-led global healthcare company with a special purpose to improve the quality of human life....Dividend calendar.Dividend timetable for Q1 2022Ex-dividend date*Thursday 19 May 2022Record dateFriday 20 May 2022Last date for DRIP electionsThursday 16 June 2022PayableThursday 7 July 20221 more row
What is the ex-dividend date for GSK?
GlaxoSmithKline plc (GSK) Ordinary 25pTypeAmountEx-dividend dateQ219.00p13/08/2020Q119.00p14/05/2020Total80.00pQ423.00p20/02/202021 more rows
Is GlaxoSmithKline a buy right now?
11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for GlaxoSmithKline in the last twelve months. There are currently 1 sell rat...
How has GlaxoSmithKline's stock price been impacted by Coronavirus?
GlaxoSmithKline's stock was trading at $39.87 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organizati...
Are investors shorting GlaxoSmithKline?
GlaxoSmithKline saw a decline in short interest in the month of February. As of February 28th, there was short interest totaling 6,900,000 shares,...
When is GlaxoSmithKline's next earnings date?
GlaxoSmithKline is scheduled to release its next quarterly earnings announcement on Wednesday, April 27th 2022. View our earnings forecast for Gla...
How were GlaxoSmithKline's earnings last quarter?
GlaxoSmithKline plc (NYSE:GSK) released its earnings results on Wednesday, February, 9th. The pharmaceutical company reported $0.69 EPS for the qua...
How often does GlaxoSmithKline pay dividends? What is the dividend yield for GlaxoSmithKline?
GlaxoSmithKline declared a quarterly dividend on Wednesday, February 9th. Investors of record on Friday, February 25th will be paid a dividend of $...
Is GlaxoSmithKline a good dividend stock?
GlaxoSmithKline pays an annual dividend of $2.46 per share and currently has a dividend yield of 6.07%. GSK has a dividend yield higher than 75% of...
Who are GlaxoSmithKline's key executives?
GlaxoSmithKline's management team includes the following people: Emma N. Walmsley , Chief Executive Officer & Executive Director Iain James Macka...
Who are some of GlaxoSmithKline's key competitors?
Some companies that are related to GlaxoSmithKline include Roche (RHHBY) , Pfizer (PFE) , AbbVie (ABBV) , Eli Lilly and (LLY) , Novo Nordisk A...
What is the dividend payout ratio for GlaxoSmithKline?
Based on earnings estimates, GlaxoSmithKline will have a dividend payout ratio of 69.23% next year. This indicates that GlaxoSmithKline will be able to sustain or increase its dividend. View GlaxoSmithKline's dividend history.
How much does GlaxoSmithKline make?
GlaxoSmithKline has a market capitalization of $105.63 billion and generates $43.79 billion in revenue each year. The pharmaceutical company earns $7.38 billion in net income (profit) each year or $2.98 on an earnings per share basis.
GlaxoSmithKline Media Sentiment
Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.
Media Coverage
We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.
GlaxoSmithKline (LON GSK) News Headlines Today
Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm.
What happened
Shares of Britain-based drug company GlaxoSmithKline ( NYSE:GSK) dropped 12.4% in February, according to data provided by S&P Global Market Intelligence. Coronavirus fears were responsible for some of the drop, but not all. The company also reported quarterly earnings that didn't please investors.
So what
On Feb. 5, GlaxoSmithKline reported fourth-quarter 2019 earnings that fell short of analysts' expectations. Pricing pressure, mainly hitting its respiratory drugs, contributed to the shortfall. The company is now forecasting 2020 adjusted profit to be down as much as 4%.
Now what
Coronavirus fears will continue to whipsaw the market for an unknown period of time, so all share prices will probably be unpredictable.
GSK: technical analysis
The latest set of results knocked GSK’s share price back towards the 200-day SMA (£16.62), but once again buyers have stepped in around £16.70, according to chief market analyst at IG, Chris Beauchamp.
Plan your trading week
Get the week’s market-moving news sent directly to your inbox every Sunday. The Week Ahead gives you a full calendar of upcoming economic events, as well as commentary from our expert analysts on the key markets to watch.
Help and support
Interested in opening an account? Contact 0800 195 3100 or [email protected]
